Gertz MA - Search Results

1

Long term survival in multiple myeloma: a single institution experience in underprivileged circumstances.

Bojalil-Alvarez L, Gertz MA, Garcia-Villaseñor E, Fernández-Gutiérrez JA, Reyes-Cisneros OA, Murrieta-Alvarez I, Cantero-Fortiz Y, Ruiz-Delgado GJ, Ruiz-Argüelles GJ. Bojalil-Alvarez L, et al. Among authors: gertz ma. Leuk Lymphoma. 2022 May;63(5):1236-1241. doi: 10.1080/10428194.2021.2012665. Epub 2021 Dec 13. Leuk Lymphoma. 2022. PMID: 34898338

2

Current therapy for multiple myeloma.

Rajkumar SV, Gertz MA, Kyle RA, Greipp PR; Mayo Clinic Myeloma, Amyloid, and Dysproteinemia Group. Rajkumar SV, et al. Among authors: gertz ma. Mayo Clin Proc. 2002 Aug;77(8):813-22. doi: 10.4065/77.8.813. Mayo Clin Proc. 2002. PMID: 12173715 Review.

3

Waldenström's macroglobulinemia: a review of therapy.

Gertz MA. Gertz MA. Leuk Lymphoma. 2002 Aug;43(8):1517-26. doi: 10.1080/1042819021000002839. Leuk Lymphoma. 2002. PMID: 12400593 Review.

4

Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma.

Kumar S, Gertz MA, Dispenzieri A, Lacy MQ, Geyer SM, Iturria NL, Fonseca R, Hayman SR, Lust JA, Kyle RA, Greipp PR, Witzig TE, Rajkumar SV. Kumar S, et al. Among authors: gertz ma. Mayo Clin Proc. 2003 Jan;78(1):34-9. doi: 10.4065/78.1.34. Mayo Clin Proc. 2003. PMID: 12528875

5

Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator.

Litzow MR, Repoussis PD, Schroeder G, Schembri-Wismayer D, Batts KP, Anderson PM, Arndt CA, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Tefferi A, Noël P, Solberg LA Jr, Letendre L, Hoagland HC. Litzow MR, et al. Among authors: gertz ma. Leuk Lymphoma. 2002 Nov;43(11):2099-107. doi: 10.1080/1042819021000032962. Leuk Lymphoma. 2002. PMID: 12533034

6

Transplantation for multiple myeloma. Pertinent Questions.

Gertz M. Gertz M. Blood. 2003 Nov 15;102(10):3472-5. Blood. 2003. PMID: 14658451 No abstract available.

7

Clinical course of patients with relapsed multiple myeloma.

Kumar SK, Therneau TM, Gertz MA, Lacy MQ, Dispenzieri A, Rajkumar SV, Fonseca R, Witzig TE, Lust JA, Larson DR, Kyle RA, Greipp PR. Kumar SK, et al. Among authors: gertz ma. Mayo Clin Proc. 2004 Jul;79(7):867-74. doi: 10.4065/79.7.867. Mayo Clin Proc. 2004. PMID: 15244382

8

Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98).

Gertz MA, Rue M, Blood E, Kaminer LS, Vesole DH, Greipp PR. Gertz MA, et al. Leuk Lymphoma. 2004 Oct;45(10):2047-55. doi: 10.1080/10428190410001714043. Leuk Lymphoma. 2004. PMID: 15370249 Clinical Trial.

9

Current status of stem cell transplantation for multiple myeloma.

Gertz MA, Lacy MQ, Dispenzieri A, Hayman S. Gertz MA, et al. Curr Treat Options Oncol. 2005 May;6(3):229-40. doi: 10.1007/s11864-005-0006-1. Curr Treat Options Oncol. 2005. PMID: 15869734 Review.

10

Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma.

Nowakowski GS, Witzig TE, Dingli D, Tracz MJ, Gertz MA, Lacy MQ, Lust JA, Dispenzieri A, Greipp PR, Kyle RA, Rajkumar SV. Nowakowski GS, et al. Among authors: gertz ma. Blood. 2005 Oct 1;106(7):2276-9. doi: 10.1182/blood-2005-05-1858. Epub 2005 Jun 16. Blood. 2005. PMID: 15961515 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

950 results

Search Page